Hyloris Pharma Secures FDA Approval for Pain Treatment

The United States Food and medicine Administration has approved Hyloris Pharmaceuticals' (HYL.BR) medicine for post-operative pain

SpliceBio and Spark Therapeutics Partner To Develop Gene Therapy

SpliceBio, a genetic medicines company that uses protein splicing to develop the next generation

Glenmark Pharma Introduces New Drug For Type two Diabetes

Glenmark Pharmaceuticals Limited, a worldwide pharmaceutical firm focused on research, has launched the first triple-drug fixed-dose combination (FDC)

Roche Pharma Introduced Clinical Trial Excellence Project

Roche Pharma India announced the commencement of its Clinical Trial Excellence project in India

Chinmaya Mission Hospital Unveils AI Enabled Imaging Technology

Chinmaya Mission Hospital (CMH) has acquired a cutting-edge Siemens Healthineers Multix VA 20 x-ray system.

Abbott Launched AI Powered Imaging Software To Detect Cardiac Problems

In India, Abbot has released a new vascular imaging platform driven by Ultreon 1.0 Software

Pharma Export Rises Over 9% in September

Exports of pharmaceutical products from the country increased by 9.01 percent in September compared to the same time the previous year.

MNC Pharma Body OPPI Names Anil Matai as Director General

Anil Matai was named director general of the Organisation of Pharmaceutical Producers of India (OPPI)

Pfizer Secures FDA Nod For Ulcerative Colitis Medication

Pfizer Inc reported last week that the US FDA has authorized etrasimod, a novel ulcerative colitis medicine that the company would commercialize under the brand name Velsipity.

Navin Fluorine introduces Navin Molecular Brand

Navin Fluorine International Ltd (NFIL), part of the Padmanabh Mafatlal Group, has unveiled the new identity for its contract development

© 2025 India Pharma Outlook. All Rights Reserved.